Drug Regimen Compliance Issues in Clinical Trials and Patient Management Edited by Jean-Michel Metry Aardex Ltd., Zug, Switzerland and Urs A. Meyer University of Basel, Switzerland A patient's non-compliance with drug regimens can render drugs ineffective. This not only causes problems for the patient but also large costs for health services. Despite a renewed interest in the subject over the past few years, there is still a dearth of new ideas and perspectives. This volume is written in response to this lack, and seeks to: Address key topics, such as regulatory issues and the role of compliance in clinical care Provide pointers for trials Provide guidelines for the management of patients Explore means by which compliance can be monitored Suggest the best ways to monitor patient management Drug Regimen Compliance: Issues in Clinical Trials and Patient Management provides the basis for future steps in improving patient compliance and will be invaluable to pharmacologists, toxicologists, pharmaco-epidemiologists, clinical trial scientists, medical economists and all those prescribing drug regimens. |